| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |